Table 3.
Microorganisms isolated in patients with microbiologically proven infections with their cefepime MICs according to EUCAST clinical breakpoint defining susceptibility or resistance.
| Microorganism | MIC ≤ 0.001 mg/L | MIC ≤ 1 mg/L | MIC = 4 mg/L | MIC = 8 mg/L | MIC > 8 mg/L |
|---|---|---|---|---|---|
| Proteus species | . | 5 | . | . | . |
| Enterobacter species | . | 13 | 1 | . | 2 |
| Klebsiella species | . | 3 | . | . | 2 |
| Escherichia coli | . | 6 | 1 | . | . |
| Serratia species | . | 3 | . | . | . |
| Morganella morganii | . | 2 | . | . | . |
| Citrobacter species | . | 3 | . | . | . |
| Hafnia alvei | . | 2 | . | . | . |
| Pseudomonas aeruginosa | 8 | . | . | 4 | 3 |
Data are presented as the number of isolated pathogens. Enterobacteriaceae was susceptible to MIC ≤ 1 mg/L and resistant to MIC > 4 mg/L, and Pseudomonas spp. were susceptible to MIC ≤ 0.001 mg/L and resistant to MIC > 8 mg/L (ref EUCAST).